Literature DB >> 9169651

Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation.

Y Kishimoto1, Y Yamamoto, T Ito, N Matsumoto, H Ichiyoshi, T Katsurada, M Date, S Ohga, H Kitajima, S Ikehara, S Fukuhara.   

Abstract

We report an unusual case of a patient who was cured of one autoimmune disease (palmoplantar pustular psoriasis (PPP)) but developed another autoimmune disease (autoimmune thyroiditis) after allogeneic BMT. A 40-year-old man suffering from AML with PPP underwent allogeneic BMT from his HLA-identical sister for the treatment of AML. The patient experienced complete clearance of the cutaneous PPP despite the cessation of immunosuppressive therapy for over 2 years. However, he developed hyperthyroidism with anti-thyroglobulin antibodies 5 months after BMT, although he had showed normal thyroid functions without anti-thyroglobulin antibodies before BMT. The donor had no history of thyroid diseases and showed normal thyroid functions but was positive for anti-thyroglobulin antibodies. Thus, even when the donor is in a subclinical state, autoimmune thyroiditis may be transferred from donors to recipients by BMT.

Entities:  

Mesh:

Year:  1997        PMID: 9169651     DOI: 10.1038/sj.bmt.1700789

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

1.  Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantation.

Authors:  A C Woods; M J Mant
Journal:  Ann Rheum Dis       Date:  2006-05       Impact factor: 19.103

Review 2.  Immunotherapy of systemic sclerosis.

Authors:  Rebecca Manno; Francesco Boin
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

Review 3.  Stem cell therapy as a potential treatment option for psoriasis.

Authors:  Piyu Parth Naik
Journal:  An Bras Dermatol       Date:  2022-05-27       Impact factor: 2.113

4.  Genetic differences in bone marrow-derived lymphoid lineages control susceptibility to experimental autoimmune myocarditis.

Authors:  Haiyan S Li; Davinna L Ligons; Noel R Rose; Mehmet L Guler
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

5.  Autoimmune disease: is it a disorder of the microenvironment?

Authors:  Nagwa S El-Badri; Amal Hakki; Annabella Ferrari; Rania Shamekh; Robert A Good
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor.

Authors:  Phillip Scheinberg; Jan J Melenhorst; Jason M Brenchley; Brenna J Hill; Nancy F Hensel; Pratip K Chattopadhyay; Mario Roederer; Louis J Picker; David A Price; A John Barrett; Daniel C Douek
Journal:  Blood       Date:  2009-09-23       Impact factor: 22.113

Review 7.  Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

Authors:  Richard K Burt; Shimon Slavin; William H Burns; Alberto M Marmont
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.319

Review 8.  Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action.

Authors:  Tae-Hoon Shin; Hyung-Sik Kim; Soon Won Choi; Kyung-Sun Kang
Journal:  Int J Mol Sci       Date:  2017-01-25       Impact factor: 5.923

Review 9.  Stem Cells as Potential Candidates for Psoriasis Cell-Replacement Therapy.

Authors:  Agnieszka Owczarczyk-Saczonek; Magdalena Krajewska-Włodarczyk; Anna Kruszewska; Waldemar Placek; Wojciech Maksymowicz; Joanna Wojtkiewicz
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.